Latest News of EBET
DRI Healthcare Trust Acquires Royalty in Pre-Approval Sebetralstat for Up to $179 Mln
By MarketWatch |
2 weeks ago
DRI Healthcare Trust bought a royalty interest in Sebetralstat, a drug for hereditary angioedema, for $179 million. The drug is in the approval process with the FDA and EMA, potentially becoming the f...
Is Goldman Sachs ActiveBeta World Low Vol Plus Equity ETF (GLOV) a Strong ETF Right Now?
By Yahoo! Finance |
3 months ago
The Goldman Sachs ActiveBeta World Low Vol Plus Equity ETF (GLOV) is a smart beta ETF offering exposure to Broad Developed World ETFs. It aims to outperform by tracking non-cap weighted strategies, di...